TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,050 | +50.2% | 700 | 0.0% | 0.00% | – |
Q4 2022 | $699 | -30.1% | 700 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -50.0% | 700 | -17.6% | 0.00% | – |
Q4 2021 | $4,000 | -89.5% | 850 | -81.1% | 0.00% | – |
Q3 2021 | $38,000 | -89.9% | 4,506 | -80.3% | 0.00% | -100.0% |
Q2 2021 | $375,000 | -25.3% | 22,874 | +0.7% | 0.00% | 0.0% |
Q1 2021 | $502,000 | -24.3% | 22,724 | +6.1% | 0.00% | 0.0% |
Q4 2020 | $663,000 | +4635.7% | 21,415 | +2959.3% | 0.00% | – |
Q3 2020 | $14,000 | +27.3% | 700 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | +120.0% | 700 | 0.0% | 0.00% | – |
Q1 2020 | $5,000 | -16.7% | 700 | +75.0% | 0.00% | – |
Q4 2019 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $6,076,298 | 2.53% |
MPM BioImpact LLC | 3,370,982 | $5,056,473 | 1.31% |
TANG CAPITAL MANAGEMENT LLC | 3,399,745 | $5,099,618 | 0.76% |
Newtyn Management, LLC | 1,015,920 | $1,523,880 | 0.30% |
Artal Group S.A. | 750,000 | $1,125 | 0.07% |
Long Focus Capital Management, LLC | 566,270 | $849,405 | 0.05% |
Redmile Group, LLC | 658,336 | $987,504 | 0.04% |
HARBOR CAPITAL ADVISORS, INC. | 67,642 | $101,463 | 0.03% |
X-Square Capital, LLC | 31,720 | $48 | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 71,046 | $106,569 | 0.02% |